Search results for "Infarction"

showing 10 items of 1208 documents

Short-Term Prognosis of Juvenile Myocardial Infarction

2016

In our early research regarding the hemorheological pattern in patients with acute myocardial infarction (AMI) with a mean age of 61.45 + 10.99 years, we showed that the major hemorheological parameters were almost normalized 2 weeks after the acute event. In the last decade, we focused on hemorheological parameters in juvenile myocardial infarction (JMI), defined as AMI in patients aged 45 years, in the ‘‘Sicilian study on juvenile myocardial infarction’’. Juvenile myocardial infarction is responsible for 2% to 10% of all cases with AMI in different surveys. Juvenile myocardial infarction presents a typical pattern of risk factors and shows clinical, angiographic, and prognostic characteri…

AdultMalemedicine.medical_specialtyTime FactorsIschemic heart diseaseBlood viscosity030204 cardiovascular system & hematologyBlood rheology030218 nuclear medicine & medical imagingAnginaCoronary artery diseasePlasma03 medical and health sciences0302 clinical medicineRisk FactorsDiabetes mellitusInternal medicinemedicineHumansMyocardial infarctionAge of OnsetRisk factorNon-ST Elevated Myocardial InfarctionBlood rheology; Myocardial infarction; Ischemic heart diseaseMedicine (all); Cardiology and Cardiovascular Medicinebusiness.industryMedicine (all)HemodynamicsBlood ViscosityPrognosismedicine.diseaseMyocardial infarctionHeart failureCoronary vesselDisease ProgressionCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessAngiology
researchProduct

Prognostic Value of a Comprehensive Cardiac Magnetic Resonance Assessment Soon After a First ST-Segment Elevation Myocardial Infarction

2009

ObjectivesTo evaluate the prognostic value of a comprehensive cardiac magnetic resonance (CMR) assessment soon after a first ST-segment elevation myocardial infarction (STEMI).BackgroundCMR allows for a simultaneous assessment of wall motion abnormalities (WMA), WMA with low-dose dobutamine (WMA-dobutamine), microvascular obstruction, and transmural necrosis. This approach has been proven to be useful to predict late systolic recovery soon after STEMI. Its prognostic value and the relative prognostic weight of these indexes are not well-defined.MethodsWe studied 214 consecutive patients with a first STEMI treated with thrombolytic therapy or primary angioplasty discharged from hospital. In …

AdultMalemedicine.medical_specialtyTime FactorsMagnetic Resonance Imaging CineInfarctionKaplan-Meier EstimateRisk Assessmentcardiac magnetic resonanceNecrosisPredictive Value of TestsRecurrenceRisk FactorsDobutamineInternal medicinemedicineHumansThrombolytic TherapyRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedProportional Hazards ModelsHeart Failurebusiness.industryMyocardiumAdrenergic beta-AgonistsMiddle Agedmedicine.diseaseCoronary VesselsMyocardial ContractionTreatment Outcomemyocardial infarctionRadiology Nuclear Medicine and imagingHeart failureMicrovesselscardiovascular systemCardiologyMyocardial infarction complicationsFemaleDobutamineprognosisMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessTIMIMacemedicine.drugJACC: Cardiovascular Imaging
researchProduct

Oxidative stress in young subjects with acute myocardial infarction: evaluation at the initial stage and after 12 months.

2007

In 105 subjects (97 men and 8 women) aged <46 years (mean age 39.6 ± 5.5 years), with recent acute myocardial infarction (T1), thiobarbituric acid reactive substances and total antioxidant status were determined; NO production was evaluated by measuring the nitrite and nitrate (NOx) concentration. The patients with acute myocardial infarction were subdivided according to the main risk factors, number of risk factors, and extent of coronary lesions. The evaluation was repeated after 12 months (T2). In these subjects, thiobarbituric acid reactive substances and NOx were significantly increased and total antioxidant status was significantly decreased at T1. In single risk factor, only NO m…

AdultMalemedicine.medical_specialtyTime FactorsThiobarbituric acidMyocardial Infarctionmedicine.disease_causeNitric OxideGastroenterologyNitric oxideLipid peroxidationchemistry.chemical_compoundRisk FactorsInternal medicineMedicineHumansMyocardial infarctionStage (cooking)Risk factorNitritebusiness.industryacute myocardial infarction in young peopleHematologyGeneral Medicineoxidative statuMiddle Agedmedicine.diseaseSurgeryOxidative StresschemistryAcute DiseaseFemaleLipid PeroxidationbusinessOxidative stressClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Immediate versus delayed facilitated percutaneous coronary intervention. A pilot study

2005

The study was aimed to investigate the outcomes in patients initially successfully treated pharmacologically and immediate PCI <2 hours, and in patients initially successfully treated with pharmacological therapy and delayed PCI (12-72 hours). All patients had to have successful reperfusion, to receive the combination of a standard abciximab infusion plus half dose rtPA. Similar results were observed in both groups. Delayed PCI group showed a favorable trend in restenosis and bleedings (ns) and a significant reduced angiographic evidence of thrombus formation in IRA. Our very preliminary data suggest the safety and possible use of delayed facilitated PCI in patients with STEMI. The studied …

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentAbciximabMyocardial InfarctionMyocardial IschemiaEligibility DeterminationMyocardial ReperfusionPilot ProjectsAcute myocardial infarctionElectrocardiographyImmunoglobulin Fab FragmentsRestenosisInternal medicinemedicineAbciximabHumansIn patientcardiovascular diseasesThrombusAngioplasty Balloon CoronaryFacilitated pciDelayed percutaneous coronary interventionPharmacologybusiness.industryPatient SelectionPercutaneous coronary interventionAntibodies MonoclonalMiddle Agedmedicine.diseaseSurvival RateGIIb/IIIa inhibitorssurgical procedures operativeTreatment OutcomeTissue Plasminogen ActivatorConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinessFacilitated percutaneous coronary interventionTIMIPlatelet Aggregation InhibitorsCombined therapymedicine.drug
researchProduct

Vitamin D, precocious acute myocardial infarction, and exceptional longevity

2015

Recent studies have reported low circulating levels of 25-hydroxyvitamin D (25(OH)D), the biologically active form of vitamin D, in patients with cardiovascular disease (CVD) [1], hypertension [2], carotid atherosclerosis [3], atrial fibrillation [4], and heart failure [5]. Moreover, vitamin D deficiency has been associated with all-cause mortality [6,7] and predicts adverse cardiac events in patients with established CVD [8] or after acute myocardial infarction (AMI) [9]. In turn, vitamin D supplementation improves the modulation of autonomic tone [10]. 4.638 JCR (2015) Q1, 24/124 Cardiac and cardiovascular systems UEM

AdultMalemedicine.medical_specialtyVitamina Dmedia_common.quotation_subjectLongevityEnfermedad cardiovascularAncianoMyocardial InfarctionCentenariosInternal medicineHealthy volunteersVitamin D and neurologyHumansMedicinecardiovascular diseasesMyocardial infarctionVitamin Dmedia_commonAged 80 and overbusiness.industryLongevityVitamina dmedicine.diseaseHealthy VolunteersEndocrinologyLongevidadAcute DiseaseCardiologyFemaleInfarto de miocardioCardiology and Cardiovascular MedicinebusinessAncianosInternational Journal of Cardiology
researchProduct

Beta-Thromboglobulin and Platelet Factor 4 in Juvenile Myocardial Infarction

2006

AdultMalemedicine.medical_specialtybusiness.industryAge FactorsMyocardial InfarctionHematologyGeneral Medicine030204 cardiovascular system & hematologyPlatelet Factor 4beta-Thromboglobulinmedicine.disease03 medical and health sciences0302 clinical medicineBeta-thromboglobulinInternal medicinemedicineCardiologyHumansJuvenileFemale030212 general & internal medicineMyocardial infarctionbusinessPlatelet factor 4Clinical and Applied Thrombosis/Hemostasis
researchProduct

Comparative epidemiology of stroke and acute myocardial infarction: the Dijon Vascular Project (DIVA)

2009

Despite a common pathophysiological mechanism (ie, atherosclerosis) and similar vascular risk factors, few reliable studies have compared the epidemiology of stroke and acute myocardial infarction (AMI).All first ever cases of stroke and AMI in Dijon, France (151 846 inhabitants) from 2001 to 2006 were prospectively recorded. The 30 day case fatality rates (CFRs) and vascular risk factors were assessed in both groups.Over the 6 years, 1660 events (1020 strokes and 640 AMI) were recorded. Crude incidence of stroke was higher than that of AMI (112 vs 70.2/100 000/year; p0.001). With regard to sex, the relative incidence of stroke compared with AMI was 0.88 (95% CI 0.60 to 1.29; p = 0.51) in w…

AdultMalemedicine.medical_specialtyhealth care facilities manpower and servicesHypercholesterolemiaMyocardial InfarctionKaplan-Meier Estimate030204 cardiovascular system & hematology03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusEpidemiologyCase fatality rateNEUROEPIDEMIOLOGYDiabetes MellitusmedicineHumansEPIDEMIOLOGYNeuroepidemiologyRegistriesMyocardial infarctioncardiovascular diseasesStrokehealth care economics and organizationsAgedVascular diseasebusiness.industryIncidence (epidemiology)Middle Agedmedicine.disease3. Good healthSurgeryPsychiatry and Mental healthHyperglycemiaAcute DiseaseFemaleSurgeryFranceNeurology (clinical)business030217 neurology & neurosurgerySTROKE
researchProduct

Association between a comprehensive smoking ban and hospitalization for acute myocardial infarction: An observational study in the Autonomous Communi…

2020

Objective: To assess the association between a comprehensive smoking ban and hospitalization rates for acute myocardial infarction (AMI). Methods: An observational study was conducted to assess changes in hospital admission rates for AMI in the Autonomous Community of Valencia, Spain (population 5 million), during the period 1995-2013. Law 28/2005 prohibited smoking in all enclosed spaces (public and private), and Law 42/2010 extended the ban to bars and restaurants as well as children's playgrounds and access areas of schools and hospitals. Data on hospital admissions were obtained from the Hospital Discharge Database (CMBD) of the Autonomous Community. Annual hospital admission rates per …

AdultMalemedicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemPopulationEnfarte do miocárdio/prevenção e controloMyocardial InfarctionAdmissão de doentes03 medical and health sciencesYoung Adult0302 clinical medicineCessação tabágica/legislação e jurisprudênciaPolítica de saúdeHealth careSocietal perspectivemedicineHumans030212 general & internal medicineMyocardial infarctioneducationhealth care economics and organizationsGeneral Environmental ScienceAgedAged 80 and overeducation.field_of_studybusiness.industryHospital discharge databaseMiddle Agedmedicine.diseaseHospitalizationSmoke-Free Policy030228 respiratory systemTabagismo/prevenção e controloSpainlcsh:RC666-701Hospital admissionEmergency medicineGeneral Earth and Planetary SciencesObservational studyFemaleSmoking banCardiology and Cardiovascular MedicinebusinessRevista Portuguesa de Cardiologia
researchProduct

The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outc…

2008

Aims We sought to determine the association between two major biomarkers, the inactive N-terminal fragment of brain natriuretic peptide (NT-proBNP) and tissue inhibitor of metalloproteinase-1 (TIMP-1) and long-term cardiovascular outcomes in a cohort of subjects who had a myocardial infarction or unstable angina 3–36 months previously. Methods and results Plasma NT-proBNP and TIMP-1 were measured in a nested case control study of 250 randomly matched subject pairs enrolled in the long-term intervention with pravastatin in ischaemic disease (LIPID) and LIPID extended follow-up studies. Cases ( n = 250) were defined as those who had a cardiovascular death, non-fatal myocardial infarction or s…

AdultMalemedicine.medical_specialtymedicine.drug_classMyocardial InfarctionCoronary AngiographyGastroenterologyLeukocyte CountRisk FactorsInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumansAngina UnstableAgedPravastatinTissue Inhibitor of Metalloproteinase-1Framingham Risk Scorebusiness.industryAnticholesteremic AgentsCase-control studyOdds ratioMiddle AgedPrognosisBrain natriuretic peptidePeptide FragmentsC-Reactive ProteinEndocrinologyQuartileCase-Control StudiesNested case-control studyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersPravastatinmedicine.drugEuropean Heart Journal
researchProduct

Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study

2009

Objective To examine the influence of age on the predictive value of N-terminal pro-brain natriuretic (NT-proBNP) peptide assay in acute myocardial infarction. Design Prospective observational study. Setting All intensive care units in one French region. Participants 3291 consecutive patients admitted for an acute myocardial infarction, from the RICO survey (a French regional survey for acute myocardial infarction). Main outcome measure Cardiovascular death at 1 year. Results Among the 3291 participants, mean age was 68 (SD 14) years and 2356 (72%) were men. In the study population, the median NT-proBNP concentration was 1053 (interquartile range 300-3472) pg/ml. Median values for age quart…

AdultMalemedicine.medical_specialtymedicine.drug_classMyocardial InfarctionIschaemic Heart DiseaseDrugs: Cardiovascular SystemPredictive Value of TestsInterquartile rangeInternal medicineIntensive careNatriuretic Peptide BrainFluid Electrolyte and Acid-Base DisturbancesmedicineNatriuretic peptideHumansProspective Studiescardiovascular diseasesMyocardial infarctionProspective cohort studyAgedGeneral Environmental ScienceAged 80 and overFramingham Risk Scorebusiness.industryResearchAdult Intensive CareDiabetesGeneral EngineeringGeneral MedicineMiddle AgedPrognosismedicine.diseaseBrain natriuretic peptidePeptide FragmentsSurgeryHospitalizationCardiovascular DiseasesPredictive value of testsHypertensionGeneral Earth and Planetary SciencesFemaleFrancebusinessBiomarkersBMJ
researchProduct